# ChromX Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chromx-health

- Industry: Medical Devices & Equipment
- Headquarters: Guangzhou, China
- Website: www.chromxhealth.com
- Latest round: Angel (Jun 1, 2021)
- Investors on record: 1

## About

Established in 2021 and based in Guangzhou, China, ChromX Health is an intelligent health technology company. In July 2023, the firm raised pre-series A funding co-led by new investor Fosun Capital. Other returning investor Guangdong Guangdong-Hong Kong-Macao Greater Bay Area Collaborative Innovation Research Institute, new investors Guangzhou Kexuecheng Venture Investment, and Shanghai Juntiancheng also participated in the round. Junqi Wang, the founder and CEO of the company, has served as CTO at Targeted Compound Monitoring, LLC and Kindwell Inc. The company has cooperated with companies such as Beijing Ditan Hospital and Xijing Hospital. In June 2025, ChromX Health raised a of pre-series A+++ funding from new investor Guangzhou GuangDian PingYun Industry Investment. The main product of the company is the prototype of expiratory VOC detection equipment. The expiratory VOC analyzer is a small gas analysis instrument with high sensitivity and high resolution. Exhalation metabolomics was combined with big data, AI technology algorithm and computing power, and VOC markers of disease were identified at the clinical level. Exhalation VOC detection has entered the industrialization stage. Full spectrum analysis of volatile metabolites is carried out through expiratory VOC analyzer, which can realize accurate diagnosis, early warning, curative effect and disease progression tracking for infectious diseases, chronic diseases, cancer and other diseases. In the future, ChromX Health will focus on cancer early screening and early diagnosis, infectious disease detection, critical medical disease diagnosis and chronic disease management. ChromX Health will also actively carry out large-scale clinical cooperation with hospitals to establish a database of VOC markers for expiratory diseases in Chinese population.

## Funding rounds

- Angel, Jun 1, 2021 — ZhenFund

## Investors

- ZhenFund (https://capitalatlas.ai/funds/zhenfund) — Angel